A Study of BRCA1 Gene Exon 2 Mutation in Bangladeshi Female Breast Cancer Patients

Jayasree Basu, Zinnat Ara Yesmin, Taslima Hossain, Rayhan Shahrear


Background: Breast cancer is the most common malignancy and leading cause of death among women in Bangladesh. Mutations in BRCA genes increase the risk for breast cancer. A large number of distinct mutations and polymorphisms in the BRCA1 gene have been reported worldwide, a frameshift mutation in BRCA1 gene exon 2 (185delAG) is one of the commonly reported mutations. Therefore, the study was planned to determine the frequencies of mutation and polymorphisms in BRCA1 gene exon 2. Materials and Methods: A cross-sectional descriptive type of study was done on 100 adult Bengali Bangladeshi female patients with ductal carcinoma of breast of age range between 25 to 70 years by ‘selection checklist.’ Genomic DNA was isolated from the peripheral blood samples. Amplification of the desired sequence of BRCA1 exon 2 was checked in gel and then digested with restriction endonuclease enzyme (Hinfl). The fragments obtained were analyzed on a gel and photographed under UV light. Sanger sequencing was done on 10 blood samples for confirmation. Sequenced data was analyzed by Geneious Software version 11. Results: The onset of cancer was predominantly below 50 years and 44% of patients did not experience menopause as they developed cancer at a younger age. Gel photographs after enzyme digestion showed wild-type bands of 149bp in all samples. The chromatogram reveals wild-type sequence of exon 2 of BRCA1 gene. Conclusions: BRCA1 mutation status helps us in the cancer risk prediction, selection of therapeutic management and genetic counseling of the patients and families. Therefore, it is necessary to study the whole BRCA1 gene in our population.


BRCA1, 185delAG, RFLP, Gel photographs, Wild-type band

Full Text:



Globocan 2018. Breast- global Cancer Observatory-iarc 2018.

NICRH (2015). Hospital-based Cancer Registry Report 2014. Department of Cancer Epidemiology, National Institute of Cancer Research and Hospital (NICRH), Mohakhali, Dhaka, pp 2-21.

Zayas-Villanueva OA, Luis Daniel C-A, Lugo-Trampe JJ, Hernández-Barajas D, González-Guerrero JF, Noriega-Iriondo MF et al. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case–control study. BMC Cancer 2019; 19(722): p- 2.

Meindl A, Ditsch N, Kast K, Rhiem K, Schmutzler RK. Hereditary breast & ovarian cancer: New genes, new treatments, new concepts. Dtsch Arztebl International 2011; 108(19): 323–330.

Bhatta B, Thapa R, Shahi S, Bhatta Y, Pandeya DR, Poudel BR. A pilot study on screening for BRCA1 mutations (185DelAG, 1294Del40) in Nepalese breast cancer patients. Asian Pacific Journal of Cancer Prevention 2016; 17(4): 1829-1832.

Karami F, Mehdipour PA. Comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. BioMed Research International 2013; 2013(928562): 1-21.

Hartwig M, Janiszewska H, Bąk A, Pilarska M, Heise M, Junkiert-Czarnecka A et al. Prevalence of the BRCA1 c.68_69delAG (BIC: 185delAG) mutation in women with breast cancer from north-central Poland and a review of the literature on other regions of the country. Contemporary Oncology (Poznan) 2013; 17(1): 34-37.

Chakraborty A, Banerjee D, Basak J, Mukhopadhyay A. Absence of 185delAG and 6174delT mutations among breast cancer patients of Eastern India. Asian Pacific Journal of Cancer Prevention 2014; 16(17): 7929-7933.

Mary A, Rajan A, Selvi R, Paul SFD. A pilot study on screening for 185delAG mutation in breast cancer patients in a tertiary care center from South India. Sri Ramachandra Journal of Medicine 2010; 3(2): 9-11.

Kim H, Choi DH. Distribution of BRCA1 and BRCA2 mutations in Asian patients with breast cancer. J Breast Cancer 2013; 16(4): 357-365.

Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M. The founder mutations 185delAG & 5382insC in BRCA1 & 6174delT in BRCA2 appear in 60% of ovarian cancer & 30% of early-onset breast cancer patients among Ashkenazi women. American Jounal of Human Geneics 1997; 60: 505-514.

Shiovitz, Korde. Genetics of breast cancer: a topic in evolution. Annals of Oncology 2015; 26 (7):1291-1299.

Sharma S, Rajaram S, Sharma T, Goel N, Agarwal S, Banerjee BD. Role of BRCA1 and BRCA2 gene mutations in epithelial ovarian cancer in Indian population: A pilot study. International Journal of Biochemistry and Molecular Biology 2014; 5(1): 1-10.

Jaure, O, Alonso, EN, Braico, DA, Nieto, A, Orozco, M, Morelli, C, Ferro, AM, Elena B, Vincent, E, Martínez, D, Martínez, I, Maegli, MI, Frizza, A, Kowalyzyn, R, Salvadori, M, Ginestet, P, Donna, MLG & Balogh, GA 2015, 'BRCA1 polymorphism in breast cancer patients from Argentina', Oncology Letters, vol. 9, pp. 845-850.

DOI: https://doi.org/10.7575/aiac.abcmed.v.10n.4p.1


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

2013-2023 (CC-BY) Australian International Academic Centre PTY.LTD.

Advances in Bioscience and Clinical Medicine